Anthony Defino

ORLANDO — In 2025, improving digital marketing is key to building an ophthalmic practice, according to a speaker at Telling It Like It Is.

NEW YORK — In this presentation from OSN New York Retina, Ferhina S. Ali, MD, MPH, discusses how real-world experience with new anti-VEGF therapies is measuring up to what was seen in clinical trials.

CHICAGO — In this Healio Video Perspective from Retina Subspecialty Day at the AAO meeting, Michael S. Ip, MD, discusses the available treatments for nonproliferative diabetic retinopathy.

AURN001, an allogeneic cell therapy candidate, achieved positive results in a phase 1/2 clinical trial for the treatment of corneal edema secondary to corneal endothelial dysfunction, according to a press release from Aurion Biotech.

Bausch + Lomb acquired Elios Vision, including its technology to perform a minimally invasive glaucoma surgery procedure with an excimer laser, according to a press release.

In this Healio Video Perspective, Cynthia Matossian, MD, FACS, and David Evans, PhD, MBA, overview the advantages and disadvantages of using AI to build an ophthalmology practice website. Evans said that AI may be able to lay out a website to be more intuitive and offer advantages in cost. However, AI falls short when it comes to personalization and customization.

Shawn Millerick has been appointed as president of vision care, Americas, at Johnson & Johnson, according to a press release.“I am honored to step into the role of president, vision care, Americas, and lead our organization into its next phase of growth and innovation,” Millerick told Healio. “With a deep commitment to advancing patient care and outcomes, I will be

NEW YORK — In this Healio Video Perspective from OSN New York, John A. Hovanesian, MD, FACS, of Harvard Eye Associates discusses three tools to improve cataract surgery planning. The Veracity surgery planner from Zeiss, the SMARTCataract planner from Alcon and the Eyetelligence platform from Bausch + Lomb are designed to provide ophthalmologists a more streamlined and less error-prone way

NEW YORK — In this Healio Video Perspective from OSN New York Retina, Rishi P. Singh, MD, FASRS, of Cleveland Clinic Florida discusses the need for anti-VEGF biosimilars and the possibility of on-label bevacizumab. According to Singh, increased availability of anti-VEGF biosimilars will improve patient access and decrease cost of care. He also discussed the impact of the recent shortage of

NEW YORK — In this Healio Video Perspective from OSN New York Retina, Lejla Vajzovic, MD, FASRS, of Duke Eye Center in Durham, North Carolina, discusses the adoption of therapies for the treatment of geographic atrophy.“There is a big need for identifying technologies that will not only help us identify patients who will benefit but also see the effect of the therapy we are using,